Cargando…
Novel insights into a treatment for aplastic anemia based on the advanced proliferation of bone marrow-derived mesenchymal stem cells induced by fibroblast growth factor 1
Aplastic anemia (AA) is rare disease that is predominantly observed in adolescents. Without effective management at an early stage, is associated with a high risk of mortality. Bone marrow mesenchymal stem cells (BMSCs) can differentiate into various types of cell, which are able to produce a number...
Autores principales: | JIANG, SHAYI, XIA, MIN, YANG, JINGWEI, SHAO, JINGBO, LIAO, XUELIAN, ZHU, JIASHI, JIANG, HUI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758337/ https://www.ncbi.nlm.nih.gov/pubmed/26460236 http://dx.doi.org/10.3892/mmr.2015.4421 |
Ejemplares similares
-
Bone and bone marrow involvement in neuroblastoma: A case report
por: Huang, Can, et al.
Publicado: (2020) -
Enhanced Adipogenicity of Bone Marrow Mesenchymal Stem Cells in Aplastic Anemia
por: Tripathy, Naresh Kumar, et al.
Publicado: (2014) -
Dioscin Regulating Bone Marrow Apoptosis in Aplastic Anemia
por: Zhang, Le, et al.
Publicado: (2022) -
Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia
por: Gonzaga, Vivian Fonseca, et al.
Publicado: (2017) -
Bone Marrow Plasma Cytokine Signature Profiles in Severe Aplastic Anemia
por: Liu, Bingnan, et al.
Publicado: (2020)